Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP /MediaPunch

RMID:RRR4A9

Preview

Image details

Contributor:

MediaPunch Inc / Alamy Stock Photo

Image ID:

RRR4A9

File size:

16.8 MB (552.1 KB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

3000 x 1963 px | 25.4 x 16.6 cm | 10 x 6.5 inches | 300dpi

Date taken:

26 February 2019

Photographer:

Media Punch

More information:

This image could have imperfections as it’s either historical or reportage.

Available for editorial use only. Get in touch for any commercial

or personal uses

Search stock photos by tags

Similar stock images

RM2MKE480–From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance

RMRRR4A0–Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP /MediaPunch

RMRRR3NC–Washington, United States Of America. 26th Feb, 2019. Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP | usage worldwide Credit: dpa/Alamy Live News

RMRRR5JB–Washington, District of Columbia, USA. 26th Feb, 2019. Albert Bourla, DVM, Ph.D., Chief Executive Officer of.Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP Credit: Chris Kleponis/CNP/ZUMA Wire/Alamy Live News

RMRRR767–Washington, United States. 26th Feb, 2019. Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP/AdMedia/Newscom/Alamy Live News

RM2DEAACY–Albert Bourla, DVM, Ph.D., Chief Executive Officer ofPfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, USA, February 26, 2019. - A Covid-19 vaccine being developed by Pfizer and Germany’s BioNTech has been found to be more than 90 per cent effective, in a breakthrough that could make the shot available for use by the end of the year if drug authorities give it the green light. Photo by Chris Kleponis/CNP/ABACAPRESS.COM

RM2EMHB5E– Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis / CNP/Sipa USA

RM2MKE3T6–From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Com

RMRRR3ME–Washington, United States Of America. 26th Feb, 2019. Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP | usage worldwide Credit: dpa/Alamy Live News

RMRRR5H9–Washington, District of Columbia, USA. 26th Feb, 2019. Albert Bourla, DVM, Ph.D., Chief Executive Officer of.Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP Credit: Chris Kleponis/CNP/ZUMA Wire/Alamy Live News

RMRRR720–Washington, United States. 26th Feb, 2019. Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP/AdMedia/Newscom/Alamy Live News

RM2DEAAD1–Albert Bourla, DVM, Ph.D., Chief Executive Officer ofPfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, USA, February 26, 2019. - A Covid-19 vaccine being developed by Pfizer and Germany’s BioNTech has been found to be more than 90 per cent effective, in a breakthrough that could make the shot available for use by the end of the year if drug authorities give it the green light. Photo by Chris Kleponis/CNP/ABACAPRESS.COM